Psoriatic Arthritis

The clinical research activity is centered on psoriatic arthritis, with attention to treatment response in refractory disease and the identification of synovial biomarkers linked to outcomes in patients receiving ixekizumab.

• Refractory psoriatic arthritis
• Synovial biomarkers
• Inflammatory joint disease

Research interests include biomarker patterns in synovial tissue, cellular homogenates, and culture supernatants as they relate to treatment responsiveness in rheumatology.